|
|
|
|
| LEADER |
01930nam a2200325 u 4500 |
| 001 |
EB001840337 |
| 003 |
EBX01000000000000001004326 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 9780309447782
|
| 020 |
|
|
|a 030944778X
|
| 100 |
1 |
|
|a Addie, Siobhan
|
| 245 |
0 |
0 |
|a Deriving drug discovery value from large-scale genetic bioresources
|h Elektronische Ressource
|b proceedings of a workshop
|c Siobhan Addie, Amanda Wagner Gee, Steve Olson, and Sarah H. Beachy, rapporteurs, Roundtable on Genomics and Precision Health, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine
|
| 260 |
|
|
|a Washington, DC
|b National Academies Press
|c [2016], 2016
|
| 300 |
|
|
|a 1 PDF file (xxi, 92 pages)
|b illustrations
|
| 653 |
|
|
|a Drug Industry
|
| 653 |
|
|
|a Drug Discovery
|
| 653 |
|
|
|a Interinstitutional Relations
|
| 700 |
1 |
|
|a Gee, Amanda Wagner
|e [rapporteur]
|
| 700 |
1 |
|
|a Olson, Steve
|e [rapporteur]
|
| 700 |
1 |
|
|a Beachy, Sarah H.
|e [rapporteur]
|
| 710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Roundtable on Genomics and Precision Health
|
| 710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Forum on Drug Discovery, Development, and Translation
|
| 710 |
2 |
|
|a Deriving Drug Discovery Value from Large-Scale Genetic Bioresources (Workshop) (2016, Washington, D.C.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK384666
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The process of discovering and developing a new drug or therapy is extremely costly and time consuming, and recently, it has been estimated that the creation of a new medicine costs on average more than
|